In chronic or advanced RA, however, a Th1/Th17-dominant milieu prevails, and synovial T cells become resistant to Th2 polarization, thereby limiting IL-4’s anti-inflammatory function. The gene discussed is IL4; the disease is rheumatoid arthritis.